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Abstract 
Background: Despite falling incidence and mortality since the turn of the century, malaria remains an important 
global health challenge. In the future fight against malaria, greater emphasis will have to be placed on understanding 
and addressing malaria caused by the Plasmodium vivax parasite. Unfortunately, due to years of neglect and under-
funding, there are currently many gaps in knowledge of P. vivax malaria. The aims of the present study were to explore 
the association between distance to vector breeding site and P. vivax infection in rural Ethiopia, and, secondarily, to 
test whether this association varies with age.
Methods: A prospective, cohort study of all residents in the Chano Mille Kebele in southern Ethiopia from April 2009 
to March 2011 (n = 8121). Weekly household follow up visits included screening for febrile cases (active surveillance). 
Participants were also asked to contact the local health centre if they experienced subjective fever between visits 
(passive surveillance). Plasmodium vivax infection was confirmed using microscopy by two independent readers. 
Information was collected on demographics and household characteristics including GPS-determined distance to 
vector breeding site. Data was analysed using Cox regression modelling.
Results: Overall the P. vivax infection rate was 12.3/1000 person-years (95% CI 10.5–14.5). Mean household dis-
tance to breeding site was 2449 m (range 1646–3717 m). Fully adjusted results showed very strong evidence of an 
association between proximity to breeding site and P. vivax infection: rate ratio = 3.47 (95% CI 2.15–5.60; P < 0.001) 
comparing the group closest to the breeding site (distance < 2100 m; n = 1383) to the group furthest away (dis-
tance > 2700 m; n = 2460). There was no evidence that age was an effect modifier in the association.
Conclusion: Results showed strong evidence that household proximity to vector breeding site is positively associ-
ated with P. vivax infection in rural Ethiopia, and that this association is constant across age groups. The findings might 
influence how net-distribution and indoor residual spraying campaigns are planned, help guide strategies on water 
resource development by highlighting potential health effects of man-made dams near human habitats, and add to 
current educational information given to people living close to breeding sites.
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Background
The global burden of malaria has decreased markedly 
in the last decades due in large parts to increased fund-
ing, widespread deployment of insecticide-treated bed-
nets, better diagnostics and enhanced availability of 
artemisinin-based combination therapies [1–3]. Since 
the turn of the century, malaria incidence worldwide has 
fallen by more than 60% and 17 countries have eliminated 
malaria completely, fueling optimism of global malaria 
eradication [3–7]. There is a growing awareness, how-
ever, that eradicating malaria will require a much better 
understanding of the Plasmodium vivax parasite and 
how to successfully address the challenges it presents. 
Unfortunately, research on P. vivax malaria has lagged 
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far behind research on Plasmodium falciparum malaria, 
and there are currently critical gaps in knowledge across 
a broad range of topics on P. vivax [8–14]. With accumu-
lating evidence that P. vivax infection is less benign than 
once thought [9, 11, 12, 15, 16] and that P. vivax preva-
lence might be underestimated in regions where P. vivax 
and P. falciparum coexist [17–19], there is a clear need 
for further studies.
Even though P. vivax malaria primarily affects coun-
tries in South and Southeast Asia, P. vivax malaria 
remains an important public health problem around the 
Horn of Africa [8, 10]. In Ethiopia, more than 50 million 
people are estimated to live in malaria-risk zones causing 
between 5 and 10 million clinical infections of malaria 
per year, and the rate of P. vivax infection is comparable 
to that of P. falciparum [20–23]. The number of stud-
ies on P. vivax malaria in the country has been steadily 
increasing. However, because vivax malaria is character-
ized by a high degree of local variation—in part caused 
by marked regional differences in altitude, temperature 
and rainfall—knowledge gained from one setting cannot 
necessarily be transferred to another [24, 25]. Moreover, 
malaria control programmes have been scaled up mark-
edly in the last decade, meaning results obtained from 
studies in the early parts of the century or before might 
be outdated due to changed transmission intensities and 
dynamics [26, 27].
Various risk factors for P. vivax infection have been 
investigated around the Horn of Africa, including cli-
matic parameters, bed net use, indoor residual spray-
ing, household characteristics and demographic factors 
[23, 28–41]. A few studies have investigated household 
proximity to vector breeding site as a risk factor, though 
the evidence from these studies is mixed: three studies 
found an enhanced risk [29, 30, 33], one found no differ-
ence [28], and one found a reduction in risk with increas-
ing proximity [40]. A separate study concluded that the 
association between proximity to breeding site and P. 
vivax infection is modified by age, with proximity a much 
stronger risk factor in children compared to adults [38]. 
Further research on the topic is warranted.
The aim of the present study was to investigate the 
association between distance to vector breeding site and 
P. vivax infection in rural Ethiopia, and, secondarily, to 
examine if age was an effect modifier in the association.
Methods
Design, setting and participants
The study used a prospective cohort design and was 
carried out in the rural Chano Mille Kebele in the Arba 
Minch Zuria district in Ethiopia, located about 500  km 
south of the capital Addis Ababa (kebele is the small-
est administrative unit in Ethiopia; Fig.  1). The kebele 
lies about 1200  m above sea-level and covers an area of 
roughly 2.4 km2. The study ran for 101 weeks, from April 
2009 to March 2011. The annual level of rainfall was 
650  mm in 2009 and 1057  mm in 2010. Three malaria 
related interventions were carried out over the course of 
the study period: indoor residual spraying with DDT in 
May 2009 (week 7) with an estimated coverage of 91%; a 
free net distribution campaign in March 2010 (week 48) 
with an average of 2.3 insecticide-treated nets (ITN) given 
out per household (mean household size was 5.9 persons); 
and indoor residual spraying with deltamethrin in June 
2010 (week 62) with an estimated coverage of 97.5%.
Three censuses were done over the course of the study: 
in the beginning (week 1); in the middle (week 51) and 
at the end of the study (week 101). Participants were 
recruited through the first two censuses. There were 
no inclusion or exclusion criteria except willingness to 
participate. All individuals in the Kebele enrolled in the 
study (i.e. none refused participation), with 7041 enroll-
ing at the first census and 1080 additional individuals 
at the second census (people who had moved into the 
Kebele and newborns since the first census were added 
to the cohort at the second census). The month in which 
people moved out of the Kebele or died was recorded at 
the second and third censuses. Information on demo-
graphic and socioeconomic variables were collected dur-
ing all three censuses.
Active and passive surveillance
The study team visited all participants weekly in their 
respective households for as long as they were enrolled 
in the study in order to screen for new cases of P. vivax 
and P. falciparum infections and inquire about ITN use 
(active surveillance). Any febrile participant was sent to 
the local health care centre for further testing and treat-
ment. The research team double checked at the end of 
each day that the referred febrile participants had vis-
ited the health centre. There were no recorded cases of 
referred participants failing to come to the health centre. 
Participants were also instructed to contact the health 
centre if they experienced subjective fever between the 
weekly visits (passive surveillance). Further details on 
methods and results for the P. falciparum studies can be 
found in articles by Loha et al. [36, 42, 43]. Malaria cases 
detected during the study were treated according to the 
national guidelines at the time.
All participants were informed about study procedures 
and gave verbal consent before enrollment. In the case of 
minors, verbal consent was obtained from caregivers or 
legal guardians. The study was approved by the Regional 
Health Research Ethics Review Committee of the South-
ern nations, nationalities and People’s Regional Health 
Bureau.
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Data and analysis
Clinical episodes of P. vivax infections were detected 
through either active or passive surveillance. The fol-
lowing two criteria defined a case: (i) Axillary tempera-
ture  ≥  37.5  °C during a weekly household visit (active 
surveillance) or subjective fever experienced between vis-
its resulting in participants contacting the health centre 
(passive surveillance); and (ii) positive microscopy read-
ing by two of three experienced readers using standard-
ized WHO procedures [44].
Potential vector breeding sites were investigated by 
tracking larvae of the Anopheles species, and the only 
place where larvae were found was at a swampy area 
close to Lake Abaya. During the rainy season, the area 
contains many small bodies of water formed as hoof-
prints from cattle and hippopotami fill with water when 
the lake floods. The identified breeding site is located 
about 2.5 km south-east of the centre of the Kebele. The 
position of each household was determined using global 
positioning systems coordinates, enabling the distance 
Fig. 1 Map of Ethiopia and location of households (dots) in study area (Chano Mille Kebele)
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from the household to the perimeter of the breeding site 
to be estimated to within 5–10 m accuracy (see Fig. 1). In 
order to simplify analysis and test for interaction, house-
hold proximity to breeding site was categorized into the 
following four groups: > 2700 m (used as reference cat-
egory); 2400–2700; 2100–2400; and  <  2100  m. Cut-off 
points were chosen with the aim of having evenly spaced 
groups with comparable number of participants in them.
Information on age, gender, persons living in house-
hold, education of head of household, and household 
wealth estimated through a wealth index score [42] was 
collected for all participants during the first two cen-
suses. Starting from week 5 of the study, all participants 
were asked during the weekly household visits whether 
they slept under an insecticide treated net (ITN) the 
night before the visits. ITN use fraction was calculated 
as the number of nights reportedly sleeping under a net 
divided by the total number of nights asked. Because 
ITN use increased substantially in the Kebele following 
the net distribution campaign at week 48, the follow-up 
period was split in two at this point. ITN use fraction was 
then calculated for the complete follow-up period as well 
as for the two periods before and after the campaign. For 
participants experiencing a P. vivax infection, ITN use 
fraction was calculated only for weeks prior to infection.
Participants experiencing a P. vivax infection exited 
the study at the time of their infection. For participants 
with multiple P. vivax infections, therefore, only the first 
episode was counted. The reasoning behind this was two-
fold. First, a fairly high proportion of reinfections with 
P. vivax might in fact represent relapses of the dormant 
hypnozoite stage of P. vivax rather than new infections 
from new mosquito bites [45–48]. Second, participants 
experiencing a P. vivax infection would probably increase 
their use of ITN as a result of the infection, and this 
might distort results.
T tests and Chi square tests were used evaluate poten-
tial selection bias in the groups lost to follow-up and to 
compare participants entering the study at the second 
census to participants entering at the beginning on the 
following parameters: distance to breeding site; age; gen-
der; and ITN use. Fischer’s exact test was used if there 
were few individuals in an exposure category, and non-
parametric tests if variables deviated substantially from 
normality. The Mantel–Haenszel method was used to 
obtain unadjusted P. vivax rate ratios (RR), and to do a 
preliminary confounder evaluation by comparing crude 
to confounder-adjusted associations of increasing prox-
imity to breeding site with P. vivax infection rates, adjust-
ing for one confounder in turn. Lexi’s expansion was 
applied to test if P. vivax infection rates differed before 
and after the net distribution campaign.
Multivariable analysis was done with Cox regression 
modelling. The proportional hazards assumption was 
tested both through visual inspection of a log-scaled 
Nelson Aalen plot and a more formal hypothesis test of 
proportional hazards using likelihood ratio test (LRT). 
The Cox regression model was built with a forward, step-
wise approach, with potential confounders added one 
at a time to the basic model containing only distance 
to breeding site. Gender and age were added first for a 
priori reasons. The other variables were added based on 
the strength of confounding found in bivariable analysis 
and kept in the model if they improved overall fit or were 
confounders in the multivariable model. Likelihood ratio 
test (LRT) was used to compare models, test for interac-
tion and test for departure from linear trend for distance 
to breeding site. The best-fitted Cox regression model 
without adjustments for ITN use fraction was then com-
pared to a model where use fraction for the whole period 
was included. Finally, the follow-up period was split in 
two at the point of the net distribution campaign (week 
48) so that the effect of ITN use fraction could be investi-
gated separately for the two periods.
Results
Flow of participants through the study
A total of 7041 individuals enrolled at study start. Fig-
ure  2 summarizes the flow of participants through the 
study. None of the eligible participants refused to take 
part in the study, therefore, the population at study start 
consisted of all individuals living in the Kebele in April 
2009. The percentage lost to follow-up between the first 
and second census was 19.3 (1356 of 7041 participants), 
and the percentage lost between the second census and 
the end of the study was 18.3 (1232 of 6765 participants). 
The group lost in the first period had a higher propor-
tion of males, was less likely to use bed nets regularly, and 
lived closer to the breeding site compared to those who 
remained in the study. Similarly, the group lost in the sec-
ond period had a higher proportion of males and was less 
likely to use bed nets regularly compared to those who 
remained in the study until the end, however, the group 
lived further away from the breeding site. Participants 
entering the study at the second census were younger 
and lived further away from the breeding site on average 
compared to participants entering at the beginning.
Descriptive results and preliminary analysis
There were 193 P. vivax episodes in 146 participants over 
the course of the study. Of these 146 participants, 112 
experienced one episode, 24 experienced two episodes, 
seven experienced three episodes and one experienced 
four episodes. If all episodes were counted (i.e. partici-
pants were not excluded upon first infection), the overall 
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P. vivax infection rate was 15.8/1000 person-years (95% 
CI 13.7–18.2). If repeat infections were excluded, the 
overall P. vivax rate was 12.3/1000 person-years (95% 
CI 10.5–14.5). The average follow-up time for the whole 
cohort was 76.3 weeks (n = 8121), and the average time 
to first infection was 40.6 weeks (n = 146). The average 
follow-up time for participants entering at study start 
(n = 7041) and after the second census (n = 1080) was 
81.7 and 41.3 weeks, respectively, and the average time to 
first infection for the two groups was 44.3 (n = 131) and 
8.1 weeks (n = 15). Figure 3 summarizes P. vivax infec-
tion rates for 4-week periods over the course of the study.
Participants characteristics and univariable associa-
tions are summarized in Table  1. The average distance 
form participants’ households to mosquito breeding 
site for the whole cohort was 2449  m with a range of 
First census – week 1 
(April 2009)
Second census – week 51
(March 2010)
Third census – week 101
(March 2011)
7041 individuals
6765 individuals
Entered study n=1080
- 963 migrants
- 117 newborn
5533 individuals
Lost to follow up n=1232
- 1208 left study area
- 24 died
Lost to follow up n=1356
- 1313 left study area
- 43 died
Fig. 2 Flowchart of participants through study, Chano Mille Kebele, Ethiopia, April 2009 to March 2011 (n = 8121)
Fig. 3 Plasmodium vivax infection rates across study period per 1000 person years (95% CI). Asterisk: Net distribution campaign (week 48). Dagger: 
Indoor residual spraying
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1646–3717  m. The 25th, 50th and 75th‰ were 2215, 
2524 and 2738 m, respectively.
Unadjusted analysis showed strong evidence that 
increasing proximity to breeding site was associated with 
elevated rates of P. vivax infection. If modelled linearly, 
the rate of P. vivax infection increased with more than 
50% per one-category increase in proximity (RR = 1.54, 
95% CI 1.32–1.79; LRT of no departure from linearity: 
Table 1 Baseline characteristics across risk factors and unadjusted associations between risk factors and vivax infection 
rates
a The number of persons per household ranged from 1 to 17, with a mean of 5.9 and a median of 7 (used as the cut-off point)
b ITN use was recorded weekly (starting from week 5) during the regular follow-up visits to households. Participants were asked if they slept under an ITN the night 
before the visit. Use fraction was calculated as the number of nights reportedly sleeping under a ITN divided by the total number of nights asked. At week 48, there 
was a net distribution campaign in the Kebele, thus use fraction is presented both for the complete follow-up period as well as with the follow-up period split in two. 
For those with P. vivax infection, ITN use fraction was calculated only for weeks prior to infection
c P value from the Mantel–Haenszel test of RR = 1.00
Participant  
characteristics
No. of  
individuals (%)
No. with  
infection
Follow-up  
(per-years)
Rate/1000  
per-years
Rate  
ratio (RR)
95% conf. 
interval
P  valuec
Household distance to breeding site (n = 8121), m
 > 2700 2460 (30.3) 26 3670.0 7.08 Ref
 2400–2700 2527 (31.1) 33 3691.5 8.94 1.26 0.76–2.11 0.37
 2100–2400 1751 (21.6) 38 2472.5 15.37 2.17 1.32–3.57 0.002
 < 2100 1383 (17.0) 49 2044.1 23.97 3.38 2.10–5.44 < 0.001
Age at study entry (n = 8121), years
 ≥ 25 2558 (31.5) 16 4056.8 3.94 Ref
 15–24 2321 (28.6) 19 2732.8 6.95 1.76 0.91–3.43 0.09
 5–14 2175 (26.8) 69 3435.4 20.08 5.09 2.96–8.77 < 0.001
 0–4 1067 (13.1) 42 1653.1 25.41 6.44 3.62–11.46 < 0.001
Gender (n = 8121)
 Male 4227 (52.1) 82 6045.4 13.56 Ref
 Female 3894 (47.9) 64 5832.7 10.97 0.81 0.58–1.12 0.20
Household wealth (n = 8121)
 1 = wealthiest tertile 2282 (28.1) 45 3177.5 14.16 Ref
 2 3079 (37.9) 47 4599.3 10.22 0.72 0.48–1.09 0.12
 3 = poorest tertile 2760 (34.0) 54 4101.3 13.17 0.93 0.63–1.38 0.72
Education head of household (n = 8121)
 Secondary or above 1720 (21.2) 26 2574.8 10.10 Ref
 Primary 2050 (25.2) 43 3014.7 14.26 1.41 0.87–2.30 0.16
 No education 4351 (53.6) 77 6288.6 12.24 1.21 0.78–1.89 0.39
Persons living in household (n = 8121)a
 ≤ 7 4445 (54.7) 73 6619.1 11.03 Ref
 ≥ 8 3676 (45.3) 73 5259.0 13.88 1.26 0.91–1.74 0.16
Time-period
 Period 1 (week 1–48) – 76 5797.7 13.11 Ref
 Period 2 (week 
49–101)
– 70 6080.4 11.51 0.88 0.64–1.22 0.43
ITN use  fractionb
 Complete follow-up period (n = 8096) (%)
  > 50 2878 (35.6) 32 4925.0 6.50 Ref
  ≤ 50 5218 (64.4) 109 6952.2 15.68 2.41 1.63–3.58 < 0.001
 Period 1 (week 1–48) (n = 7016) (%)
  > 50 1314 (18.7) 16 1167.5 13.70 Ref
  ≤ 50 5702 (81.3) 55 4629.3 11.88 0.87 0.50–1.51 0.62
 Period 2 (week 49–101) (n = 6695) (%)
  > 50 4163 (62.2) 34 4029.0 8.44 Ref
  ≤ 50 2532 (37.8) 36 2051.4 17.55 2.08 1.30–3.32 0.002
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P =  0.77). There was also strong evidence that younger 
participants had higher rates of P. vivax infection than 
older participants, and that participants sleeping under 
a ITN ≤  50% of nights had increased rates of infection 
compared to those sleeping under a ITN > 50% of nights. 
There was weak or no evidence that the other covariates 
were associated with P. vivax infection, making them 
unlikely confounders. There was no evidence that the 
overall rate of P. vivax infection went down following the 
net distribution campaign during week 48, however, a 
much higher percentage of participants reportedly used 
bed nets more than half the nights: 19 versus 62% for the 
period before and after the net campaign, respectively.
Cox regression models
Model 1, Table  2, shows the best-fitted Cox regression 
model without adjustments for ITN use. After adjust-
ing for age at study entry, gender, persons living in 
household, education head of household and household 
wealth, there was strong evidence of increasing rates of 
P. vivax infection the closer a participant lived to the 
breeding site (P. vivax rates increased by 50% for each 
one-category increase in proximity to breeding site). If 
the group closest to the breeding site was compared to 
the group furthest away, the closest group had almost 3.5 
times the rate of P. vivax infection (RR =  3.47, 95% CI 
2.15–5.60, P < 0.001). None of the covariates confounded 
the association between distance to breeding site and P. 
vivax infection. LRT of age as an effect modifier between 
distance to breeding site and P. vivax infection gave no 
evidence of interaction. There was minimal change in 
the association between proximity to breeding site and 
P. vivax infection when ITN use fraction for the whole 
follow-up period was added (RR  =  1.56, 95% CI 1.34–
1.81, P < 0.001, Table 2, Model 2), and there was no evi-
dence that age was an effect modifier. Finally, there was 
no evidence against modelling proximity to breeding site 
linearly.
Secondarily, there was strong evidence that age was 
negatively associated with P. vivax infection (the age 
group 0–4 years had more than 5 times the rate of infec-
tion compared to the age group  ≥  25  years); and that 
ITN use fraction was negatively associated with infection 
rates (participants sleeping under a ITN 50% of nights or 
less had 85% higher rates of P. vivax infection). ITN use 
also appeared to be a positive confounder of the asso-
ciation between age and P. vivax infection, with adjusted 
RRs being pushed closer to the null of RR = 1.00 across 
all age groups.
When the follow-up period in the fully adjusted model 
was split at the point of the net distribution campaign, the 
strength of the association between distance to breeding 
site and P. vivax infection was about 10% greater for the 
first time-period, though confidence intervals overlapped 
(RR = 1.60, 95% CI 1.29–1.98 before net campaign versus 
RR = 1.46, 95% CI 1.17–1.81 after net campaign; Table 3). 
Table 2 Cox regression models with adjusted rate ratios of P. vivax infection for various risk factor levels
a Distance to breeding site was categorized into: > 2700 m (ref ); 2400–2700; 2100–2400; and < 2100 m, and modelled linearly
b ITN use was recorded weekly (starting from week 5) during the regular follow-up visits to households. Participants were asked if they slept under a ITN the night 
before the visit. Use fraction was calculated as the number of nights reportedly sleeping under a ITN divided by the total number of nights asked. For those with P. 
vivax infection, ITN use fraction was calculated only for weeks prior to infection
Model 1—no adjustments for ITN  
use fraction (n = 8121)
Model 2—adjusted for ITN use 
fraction (n = 8096)
RR (95% CI) P value RR (95% CI) P value
Increasing household proximity to breeding  sitea 1.50 (1.30–1.74) < 0.001 1.56 (1.34–1.81) < 0.001
Age at study entry
 ≥ 25 Ref Ref
 15–24 1.73 (0.89–3.36) 0.11 1.40 (0.69–2.83) 0.35
 5–14 4.71 (2.73–8.13) < 0.001 3.54 (1.95–6.43) < 0.001
 0–4 6.49 (3.64–11.55) < 0.001 5.47 (2.98–10.06) < 0.001
Gender
 Males Ref Ref
 Females 0.85 (0.61–1.18) 0.34 0.86 (0.62–1.20) 0.38
Persons living in household
 ≤ 7 Ref Ref
 ≥ 8 1.27 (0.92–1.77) 0.15 1.16 (0.83–1.63) 0.39
ITN use fraction (%)b
 > 50 Ref
 ≤ 50 1.85 (1.20–2.83) 0.005
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There was no evidence that age was an effect modifier in 
either period, and there was no evidence against model-
ling proximity to breeding site linearly.
Secondarily, there was some indication that younger 
age was a stronger risk factor for P. vivax infection in the 
first period when the overall ITN use fraction in the pop-
ulation was lower compared to in the second period.
Discussion
This 2-year prospective cohort study conducted between 
2009 and 2011 in the rural Chano Mille Kebele in south-
ern Ethiopia examined the association between P. vivax 
infection and household distance to vector breeding 
site using Cox regression modelling. The study found 
strong evidence of increasing rates of P. vivax infection 
the closer participants lived to the breeding site after 
adjusting for age, gender, persons living in household, 
education head of household, household wealth and ITN 
use. The final regression model showed that the group 
of participants who lived closest to the breeding site 
had almost 3.5 times the rate of P. vivax infection com-
pared to the group who lived furthest away. The effect of 
increasing proximity to breeding site on P. vivax infection 
rate appeared to be linear throughout the distance cat-
egories investigated. There was no evidence that age was 
an effect modifier, investigated as a secondary objective 
in the study. Other important, though post hoc, findings 
included strong evidence that age was negatively associ-
ated with P. vivax infection (rates were more than 5 times 
higher in the age group 0–4  years compared to adults 
25 years or older), and that overall ITN use was associ-
ated with reduced P. vivax infection rates. There was also 
some indication that the increased rate of P. vivax infec-
tion associated with younger age was more pronounced 
in the time-period when overall reported ITN use was 
low in the population (i.e. before the net distribution 
campaign).
The main finding of the present study, that there was 
a clear positive association between household proxim-
ity to vector breeding site and P. vivax infection, is in line 
with the study’s pre-specified hypothesis and consistent 
with the majority of evidence from similar research con-
ducted around the Horn of Africa [29, 30, 33, 38]. Loha 
et al. also found a positive association between proxim-
ity to breeding site and Plasmodium falciparum infection 
in the same study population [42]. Given how malaria is 
transmitted, it is biologically plausible that individuals 
in households close to where mosquitoes live and breed 
have increased risk of infection [16]. The female anophe-
line mosquito carrying the malaria parasite requires 
a blood-meal after mating in order for eggs to develop, 
and as the female leaves the breeding site in search of a 
suitable human host, it is logical that individuals who are 
closer to where the search starts have a higher likelihood 
Table 3 Fully adjusted Cox regression models with follow-up period split at net distribution campaign
a Distance to breeding site categorized into: > 2700 m (ref ); 2400–2700; 2100–2400; and < 2100 m, and modelled linearly
b ITN use was recorded weekly (starting from week 5) during the regular follow-up visits to households. Participants were asked if they slept under a ITN the night 
before the visit. Use fraction was calculated as the number of nights reportedly sleeping under a ITN divided by the total number of nights asked. During week 48, 
there was a net distribution campaign in the Kebele thus the follow-up period was split at this point. For those with P. vivax infection, ITN use fraction was calculated 
only for weeks prior to infection
Period 1—week 1 to 48 (n = 7016) Period 2—week 49 to 101 
(n = 6695)
RR (95% CI) P value RR (95% CI) P value
Increasing household proximity to breeding  sitea 1.60 (1.29–1.98) < 0.001 1.46 (1.17–1.81) 0.001
Age at study entry
 ≥ 25 Ref Ref
 15–24 2.73 (0.88–8.47) 0.08 1.23 (0.50–3.00) 0.65
 5–14 9.87 (3.79–25.70) < 0.001 2.43 (1.15–5.13) 0.02
 0–4 10.79 (4.03–28.92) < 0.001 4.57 (2.13–9.79) < 0.001
Gender
 Males Ref Ref
 Females 0.79 (0.49–1.27) 0.33 0.96 (0.60–1.53) 0.85
Persons living in household
 ≤ 7 Ref Ref
 ≥ 8 0.83 (0.52–1.35) 0.46 1.81 (1.11–2.97) 0.02
ITN use fraction (%)b
 > 50 Ref Ref
 ≤ 50 0.67 (0.37–1.20) 0.18 1.68 (1.01–2.79) 0.04
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of being targeted. However, it is not necessarily house-
hold proximity to breeding site per se that matters, 
rather, household proximity might be considered a strong 
positive correlate of the relative probability of being bit-
ten and infected. This probability also depends on many 
other factors. For example, Loha et  al. found evidence 
that the risk of malaria infection for individuals in a 
given household at a given distance to the breeding site 
was reduced if there were many other households lying 
between their household and the breeding site [36]. In 
other words, the spatial layout of households in a village 
in relation to the breeding site might influence malaria 
infection risk and modify the effect of proximity in and of 
itself. Similarly, it is possible that other physical charac-
teristics of a village or region—e.g. topography or vegeta-
tion—might modify the effect of proximity to breeding 
site.
The strength of the findings is supported by the clear 
stepwise increase in the rate of P. vivax infection with 
increasing proximity to breeding site. The evidence of 
linearity between proximity and P. vivax infection is 
somewhat at odds with findings from another study in 
Ethiopia where the relationship tended be exponential 
[34]. Importantly though, the distance range investigated 
in that study was 150–1250 m compared to 1646–3717 m 
in the present study. It is possible that P. vivax infection 
rates increase exponentially with proximity to breeding 
site at distances close to the breeding site and more lin-
early at distances further away.
As discussed in the limitation section below, it is hard 
to exclude selection bias resulting from loss to follow-
up. However, when the follow-up period was split at the 
point of the net distribution campaign, the evidence of 
an association between proximity to breeding site and P. 
vivax infection was strong for both periods even though 
the population in the two periods differed (due to both 
follow-up loss and the entry of new participants). This 
makes it less likely that selection bias has greatly dis-
torted the main conclusion. Misclassification and resid-
ual confounding can also not be excluded.
In terms of the study’s secondary objective of investi-
gating age as an effect modifier, there was no evidence 
neither in bivariable nor multivariable analysis to support 
this. This finding contrasts an earlier study by Peterson 
et al. which found the effect of proximity to breeding site 
to be more pronounced in younger age groups [38]. Sev-
eral reasons might explain this difference. One, the pre-
sent study was conducted in a rural setting at an altitude 
of about 1200 m versus the study by Peterson et al. which 
was done in a peri-urban setting at an altitude of 1600 m. 
Another important difference is that the study by Peter-
son et al. was of shorter duration and conducted during 
peak malaria season with consequently higher incidence 
rates of malaria over the course of the study period (the 
present study covered both peak and non-peak season). 
Though perhaps the most important differences between 
the studies were that the overall ITN use fraction was 
much lower in the study by Peterson et  al. and that the 
distance-range investigated was much closer to the 
breeding site.
The post hoc finding that younger age was strongly 
associated with higher rates of P. vivax infection is in line 
with prior research [30, 37, 39], and in accordance with 
current understanding of the development of P. vivax 
immunity [49]. Since immunity against P. vivax develops 
at an earlier age than immunity against P. falciparum, is 
was unsurprising that the youngest age group had sig-
nificantly higher P. vivax rates compared to the second 
youngest group in the present study, however, that P. fal-
ciparum rates in the same population were roughly equal 
in the two age groups [42]. The tendency that younger 
age was a much stronger risk factor for vivax infection 
in the time period before the net distribution campaign 
should be interpreted with caution given the large and 
overlapping confidence intervals. The might be a topic of 
interest for future studies.
The study did not find evidence that gender, household 
wealth or education of head of household were associ-
ated with P. vivax infection, which contrasts conclu-
sions from other studies [28, 31, 37, 40, 41]. Part of this 
discrepancy might be because the present study lacked 
power to detect these associations (versus Siri [41]); cat-
egorized variables differently (versus Graves et  al. and 
Khaireh et  al. [28, 31]; or required objective/subjective 
fever in addition to a positive RDT and microscopy read-
ing to meet P. vivax case definition (versus most other 
studies which did not require clinical signs or symptoms 
[28, 31, 37, 41]. Lastly, given that the transmission of P. 
vivax depends on many setting specific characteristics 
(e.g. altitude, rainfall, temperature), it might well be that 
a given variable is an important risk factor in one setting, 
though less important in another setting with different 
transmission patterns.
Study limitations
Loss to follow-up is a potentially important limitation to 
consider. However, because there was inconsistent evi-
dence on how loss to follow-up was associated with prox-
imity to breeding site, and because the design allowed for 
new participants midway through the study, it is difficult 
to evaluate how loss to follow-up might have affected 
results. There was consistent evidence that those lost to 
follow-up were younger and had a lower proportion with 
ITN use over 50% which would lead to an underestima-
tion of the overall rate of infection in the study (the age 
difference was small in absolute terms, thus the likely 
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biological effect of this should be limited). Since those 
lost to follow-up in addition had a higher proportion of 
males, care should be taken when generalizing to popula-
tions based on similar baseline characteristics.
The diagnosis of P. vivax with microscopy is not 
straightforward in settings where P. falciparum and 
P. vivax coexist [9, 17, 19], which could result in under 
diagnosis and/or misclassification of P. vivax malaria 
(non-differential). In terms of ITN use, it is possible that 
reported use the night before the weekly visits was too 
imprecise to adequately control for ITN as a confounder, 
resulting in residual confounding. However, a strength 
of the study was the thoroughness of the data collection 
on ITN use compared to most other studies on P. vivax 
malaria in the region. Residual confounding might also 
result from dichotomizing the ITN variable.
The decision that participants experiencing P. vivax 
infection would exit the study at the point of their first 
infectious episode might also be considered a limitation. 
That is, by excluding the contributed follow-up time after 
infection for these participants, the final model used less 
information than was available in the data-set. Nonethe-
less, because ITN use patterns likely changed for par-
ticipants as a result of being infected, and because repeat 
infections might be relapse episodes of the dormant hyp-
nozoite stage of the P. vivax parasite rather than truly 
new infections [45–48], excluding participants upon their 
first episode was deemed the best approach.
Conclusion and recommendations
The present study found strong evidence for a posi-
tive association between P. vivax infection rates and liv-
ing close to a vector breeding site. Contrary to earlier 
research, there was no evidence that this association var-
ied across age groups. The transmission dynamics of P. 
vivax malaria depend on many factors, some of which are 
highly setting specific—e.g. climate and altitude. There-
fore, care should be taken when trying to apply the find-
ings from the present study to populations in different 
settings.
The findings might influence how net-distribution and 
indoor residual spraying campaigns are planned and 
implemented, help guide strategies on water resource 
development by highlighting potential negative health 
effects of man-made dams near human habitats, and add 
to current educational information given to people living 
close to vector breeding sites.
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